Related Experiment Video

Updated: Sep 21, 2025

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
09:41

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage

Published on: July 3, 2014

15.0K

Use of Lipid-Lowering Drugs After Intracerebral Hemorrhage

Ashkan Shoamanesh1, Magdy Selim2

  • 1Department of Medicine, McMaster University, Population Health Research Institute, Hamilton, ON, Canada (A.S.).

Stroke
|June 6, 2022
PubMed

Insights

Hyperlipidemia management after intracerebral hemorrhage (ICH) is unclear. Lowering lipids may increase ICH risk, necessitating careful consideration of risks versus benefits for secondary prevention.

Area of Science:

  • Neurology
  • Cardiology
  • Vascular Medicine

Background:

  • Hyperlipidemia is prevalent in patients with intracerebral hemorrhage (ICH).
  • Secondary prevention of vascular events is crucial post-ICH due to risks of recurrence, cardiovascular disease, and ischemic stroke.
  • The role of intensive hyperlipidemia treatment post-ICH is less understood compared to ischemic stroke patients.

Purpose of the Study:

  • To review the competing risks and benefits of lipid-lowering treatments in patients with a history of ICH.
  • To outline a potential treatment paradigm based on current evidence.
  • To highlight the need for dedicated randomized trials in this population.

Main Methods:

  • Literature review of epidemiological studies and randomized trials.
  • Analysis of evidence regarding hyperlipidemia's role in ICH and the effects of lipid-lowering therapies.
  • Synthesis of current data to inform management strategies.

Main Results:

  • Epidemiological data suggest hyperlipidemia may be protective against ICH, with intensive lipid lowering potentially increasing ICH risk.
  • Few randomized trials have specifically evaluated lipid-lowering therapies in ICH survivors, limiting definitive conclusions on safety and efficacy.
  • There is currently no consensus on optimal hyperlipidemia management post-ICH.

Conclusions:

  • The optimal strategy for managing hyperlipidemia after ICH remains uncertain.
  • Balancing the risks of lipid-lowering treatments against potential benefits requires careful consideration in ICH patients.
  • Further randomized controlled trials are essential to establish evidence-based guidelines for lipid management in ICH survivors.

Keywords:
cardiovascular diseasehemorrhagehyperlipidemiaischemic strokelipid

More Related Videos

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation09:01

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation

Published on: October 15, 2021

7.8K
Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke09:41

Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke

Published on: October 1, 2020

5.3K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
900
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
44
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
934
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
29